A

Philip Morris International's wholly-owned investment subsidiary focused on consumer health, cannabinoids, and oral and intra-oral delivery therapeutics.

Lausanne, Switzerland · 2+ investments · 1 portfolio companies

Growth
Biotech
Digital Health
Headquarters
Lausanne, Switzerland
Founded
2006
Portfolio Company
1
Total Investments
2
Last Investment
May 2026
Geographic Focus
Europe

Investment Thesis

Corporate investment arm of Philip Morris International, deploying capital into consumer health, inhaled therapeutics, and oral drug-delivery innovations adjacent to PMI's harm-reduction strategy.

Aspeya is a Venture Capital firm based in Lausanne, Switzerland. It has made 2 investments, including Waterdrop. Focus areas include Biotech and Digital Health.

Portfolio1

Co-investors11

Sign up to view co-investors

11 co-investors across 11 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×8 · Corporate VC ×1 · Sovereign Wealth Fund ×1 · 2 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Aspeya on Indexed.vc
<a href="https://indexed.vc/investors/aspeya"><img src="https://indexed.vc/api/badge/investor/aspeya" alt="Aspeya on Indexed.vc" width="260" height="76" /></a>